✦ LIBER ✦

Phase III Study of Radiation Therapy With or Without Cis-Platinum in Patients With Unresectable Squamous or Undifferentiated Carcinoma of the Head and Neck: An Intergroup Trial of the Eastern Cooperative Oncology Group (E2382)

✍ Scribed by Harry Quon; Traci Leong; Robert Haselow; Bruce Leipzig; Jay Cooper; Arlene Forastiere

Book ID: 118455195
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 193 KB
Volume: 81
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2010.06.038

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III Randomized, Placebo-Controlled

Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial

✍ Argiris, A.; Ghebremichael, M.; Gilbert, J.; Lee, J.-W.; Sachidanandam, K.; Kole 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 328 KB

Randomized Phase III Trial of ABVD Versu

Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)

✍ Gordon, L. I.; Hong, F.; Fisher, R. I.; Bartlett, N. L.; Connors, J. M.; Gascoyn 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 323 KB

282 oral A phase III study of high dose

282 oral A phase III study of high dose radiation therapy with or without cetuximab in patients with locoregionally advanced squamous cell carcinoma of the head and neck

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Final report of a phase II evaluation of

Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck : An Eastern Cooperative Oncology Group trial (PA390)

✍ Arlene A. Forastiere; Darleen Shank; Donna Neuberg; Samuel G. Taylor IV; Ronald 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 2 views

The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.

Phase II study of intravesical therapy w

Phase II study of intravesical therapy with AD32 in patients with papillary urothelial carcinoma or carcinoma in situ (CIS) refractory to prior therapy with bacillus Calmette-Guerin (E3897): A trial of the Eastern Cooperative Oncology Group

✍ Jeffrey M. Ignatoff; Yu-Hui Chen; Richard Evan Greenberg; Julio M. Pow-Sang; Edw 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Prognostic factors and long-term survivo

Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck : An analysis of two Eastern Cooperative Oncology Group randomized trials

✍ Athanassios Argiris; Yi Li; Arlene Forastiere 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views